U.S., Feb. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07418125) titled 'Studying the Role of Circulating Tumor Cell Clusters in Patients With High-risk Early Breast Cancer, Study GALIA' on Feb. 03.

Brief Summary: CTCs, CTC clusters, and ctDNA may predict treatment response and survival in high-risk breast cancer, including IBC.

Study Start Date: Feb. 07, 2024

Study Type: INTERVENTIONAL

Condition: Breast Cancer

Intervention: DIAGNOSTIC_TEST: Liquid biopsy

Additional liquid biopsy to monitor disease

Recruitment Status: RECRUITING

Sponsor: Institute of Oncology Ljubljana

Published by HT Digital Content Services with permission from Health Daily Digest....